PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 55 filers reported holding PSYCHEMEDICS CORP in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $209,000 | -11.4% | 14,896 | 0.0% | 0.27% | -8.7% |
| Q4 2018 | $236,000 | -15.7% | 14,896 | 0.0% | 0.30% | +43.8% |
| Q3 2018 | $280,000 | -51.5% | 14,896 | -50.3% | 0.21% | -39.9% |
| Q2 2018 | $577,000 | -17.1% | 30,002 | -7.9% | 0.35% | -37.7% |
| Q1 2018 | $696,000 | – | 32,568 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tieton Capital Management, LLC | 250,388 | $3,974,000 | 4.46% |
| QUANTUM CAPITAL MANAGEMENT | 63,246 | $1,004,000 | 0.58% |
| Mill Road Capital Management LLC | 14,896 | $236,000 | 0.30% |
| Gs Investments, Inc. | 15,800 | $250,746,000 | 0.21% |
| RBF Capital, LLC | 87,917 | $1,395,000 | 0.18% |
| North Star Investment Management Corp. | 85,282 | $1,353,000 | 0.18% |
| CRAWFORD INVESTMENT COUNSEL INC | 297,675 | $4,724,000 | 0.16% |
| Uniplan Investment Counsel, Inc. | 145,677 | $2,311,000 | 0.16% |
| DEPRINCE RACE & ZOLLO INC | 282,186 | $4,478,000 | 0.13% |
| Moors & Cabot, Inc. | 37,932 | $605,000 | 0.10% |